The finding that co-inhibition of MET and FGFR signalling reduces but does not completely abrogate sphere formation and tumour growth in human cell lines and PDXs may suggest the involvement of other compensatory pathways, such as EGFR, which has been associated with mesenchymal TNBCs88. This evidence concerns the gene EGFR and neoplasm.